Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
1.04
-0.03 (-2.80%)
At close: Jun 23, 2025, 3:59 PM
1.05
0.96%
After-hours: Jun 23, 2025, 07:59 PM EDT
-2.80% (1D)
| Bid | 1.03 |
| Market Cap | 206.13M |
| Revenue (ttm) | 259.57M |
| Net Income (ttm) | -153.22M |
| EPS (ttm) | -0.85 |
| PE Ratio (ttm) | -1.22 |
| Forward PE | -6.29 |
| Analyst | Buy |
| Ask | 1.07 |
| Volume | 2,709,285 |
| Avg. Volume (20D) | 5,291,256 |
| Open | 1.06 |
| Previous Close | 1.07 |
| Day's Range | 0.98 - 1.07 |
| 52-Week Range | 0.69 - 3.94 |
| Beta | 0.65 |
About ESPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Esperion Therapeutics Inc. is scheduled to release its earnings on Aug 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+12.03%
Esperion Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
6 months ago
+5.58%
Esperion Therapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a price target of $8.
1 month ago · seekingalpha.com
Esperion Therapeutics, Inc. (ESPR) Q1 2025 Earnings Call TranscriptEsperion Therapeutics, Inc. (NASDAQ:ESPR ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Alina Venezia - Director of Investor Relations Sheldon Koenig - President and Ch...
